Portfolio company
AllInBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops precision immunology therapies to identify and treat patients genetically predisposed to chronic inflammatory and autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Allorion
This biotechnology company develops small-molecule drugs for patients with cancer and autoimmune diseases using its proprietary drug discovery platforms.
Altrubio
This clinical-stage biotechnology company develops antibody therapeutics to treat patients suffering from immunological and inflammatory diseases such as ulcerative colitis.
Hillstar Bio
This biotechnology company develops precision immunology therapies that target and deplete pathogenic immune cells for patients with autoimmune diseases.
Attovia Therapeutics
The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.
Merida Biosciences
This company develops precision immunology therapies to treat patients suffering from autoimmune and allergic disorders.
Alumis
This company develops oral therapies and precision medicines for patients with immune-mediated disorders including plaque psoriasis and systemic lupus erythematosus.
Immunic Therapeutics
The company develops oral therapies for chronic inflammatory and autoimmune diseases for patients with neurological and gastrointestinal conditions.
Beeline Medicines
This clinical-stage biotechnology company develops precision therapies for patients living with autoimmune and inflammatory diseases.
